HeartSciences Operating Income 2022-2024 | HSCS
HeartSciences Annual Operating Income (Millions of US $) |
|
---|---|
2023 | $-6 |
2022 | $-5 |
2021 | $-3 |
HeartSciences Quarterly Operating Income (Millions of US $) |
|
---|---|
2024-01-31 | $-2 |
2023-10-31 | $-2 |
2023-07-31 | $-1 |
2023-04-30 | $-2 |
2023-01-31 | $-1 |
2022-10-31 | $-2 |
2022-07-31 | $-1 |
2022-04-30 | $-2 |
2022-01-31 | $-1 |
2021-10-31 | $-1 |
2021-07-31 | $-1 |
2021-04-30 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.006B | $0.000B |
HeartSciences is an artificial intelligence powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The company's product candidate includes the MyoVista(R) wavECG(TM) or the MyoVista(R). HeartSciences , formerly known as Heart Test Laboratories Inc., is based in Southlake, TX. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $35.723B | 19.61 |
Inspire Medical Systems (INSP) | United States | $7.393B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.477B | 0.00 |
Axonics (AXNX) | United States | $3.412B | 0.00 |
10x Genomics (TXG) | United States | $3.208B | 0.00 |
Enovis (ENOV) | United States | $3.038B | 23.08 |
Azenta (AZTA) | United States | $2.905B | 236.82 |
Olink Holding AB (publ) (OLK) | Sweden | $2.820B | 0.00 |
Hims & Hers Health (HIMS) | United States | $2.680B | 0.00 |
Privia Health (PRVA) | United States | $2.139B | 94.89 |
Schrodinger (SDGR) | United States | $1.827B | 0.00 |
Omnicell (OMCL) | United States | $1.248B | 30.53 |
Phreesia (PHR) | United States | $1.185B | 0.00 |
Definitive Healthcare (DH) | United States | $0.821B | 0.00 |
Standard BioTools (LAB) | United States | $0.737B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.680B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.619B | 0.00 |
Talkspace (TALK) | United States | $0.536B | 0.00 |
Health Catalyst (HCAT) | United States | $0.373B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.329B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.318B | 0.00 |
Pulmonx (LUNG) | United States | $0.298B | 0.00 |
P3 Health Partners (PIII) | United States | $0.183B | 0.00 |
Butterfly Network (BFLY) | United States | $0.164B | 0.00 |
American Well (AMWL) | United States | $0.154B | 0.00 |
Outset Medical (OM) | United States | $0.147B | 0.00 |
MSP Recovery (LIFW) | United States | $0.129B | 0.00 |
Augmedix (AUGX) | United States | $0.124B | 0.00 |
TruBridge (TBRG) | United States | $0.118B | 5.04 |
111 (YI) | China | $0.088B | 0.00 |
Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.068B | 0.00 |
HeartBeam (BEAT) | United States | $0.057B | 0.00 |
Zepp Health (ZEPP) | China | $0.052B | 0.00 |
Movano (MOVE) | United States | $0.048B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
Akili (AKLI) | United States | $0.031B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.025B | 0.00 |
Cue Health (HLTH) | United States | $0.021B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
CareCloud (CCLD) | United States | $0.018B | 0.00 |
ETAO (ETAO) | United States | $0.016B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
Biotricity (BTCY) | United States | $0.013B | 0.00 |
Transgenomic (PRPO) | United States | $0.008B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
Syra Health (SYRA) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |